Prevalence and correlates of food insecurity in community-based individuals with severe mental illness receiving long-acting injectable antipsychotic treatment.


Journal

The British journal of nutrition
ISSN: 1475-2662
Titre abrégé: Br J Nutr
Pays: England
ID NLM: 0372547

Informations de publication

Date de publication:
28 08 2020
Historique:
pubmed: 3 4 2020
medline: 5 11 2020
entrez: 3 4 2020
Statut: ppublish

Résumé

People with severe mental illness (SMI) have numerous risk factors that may predispose them to food insecurity (FI); however, the prevalence of FI and its effects on health are under-researched in this population. The present study aimed to describe the prevalence of FI and its relationship to lifestyle factors in people with SMI. This cross-sectional study recruited people with SMI receiving long-acting injectable (LAI) antipsychotic medication from community services at three sites in Sydney, Australia. Assessments were completed on physical health and lifestyle factors. χ2 Tests, independent-samples t tests and binary logistic regression analyses were calculated to examine relationships between lifestyle factors and FI. In total, 233 people completed the assessments: 154 were males (66 %), mean age 44·8 (sd 12·7) years, and the majority (70 %) had a diagnosis of schizophrenia. FI was present in 104 participants (45 %). People with FI were less likely to consume fruits (OR 0·42, 95 % CI 0·24, 0·74, P = 0·003), vegetables (OR 0·39, 95 % CI 0·22, 0·69, P = 0·001) and protein-based foods (OR 0·45, 95 % CI 0·25, 0·83, P = 0·011) at least once daily, engaged in less moderate to vigorous physical activity (min) (OR 0·997, 95 % CI 0·993, 1·000, P = 0·044), and were more likely to smoke (OR 1·89, 95 % CI 1·08, 3·32, P = 0·026). FI is highly prevalent among people with SMI receiving LAI antipsychotic medications. Food-insecure people with SMI engage in less healthy lifestyle behaviours, increasing the risk of future non-communicable disease.

Identifiants

pubmed: 32234106
pii: S0007114520001191
doi: 10.1017/S0007114520001191
doi:

Substances chimiques

Antipsychotic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

470-477

Auteurs

Scott B Teasdale (SB)

School of Psychiatry, University of New South Wales, Kensington2033, Australia.

Rachel Morell (R)

School of Psychiatry, University of New South Wales, Kensington2033, Australia.

Julia M Lappin (JM)

School of Psychiatry, University of New South Wales, Kensington2033, Australia.

Jackie Curtis (J)

School of Psychiatry, University of New South Wales, Kensington2033, Australia.
Keeping the Body in Mind Program, South Eastern Sydney Local Health District, Bondi Junction2022, Australia.

Andrew Watkins (A)

Keeping the Body in Mind Program, South Eastern Sydney Local Health District, Bondi Junction2022, Australia.
Faculty of Health, University of Technology Sydney, Ultimo2007, Australia.

Philip B Ward (PB)

School of Psychiatry, University of New South Wales, Kensington2033, Australia.
Schizophrenia Research Unit, South Western Sydney Local Health District and Ingham Institute of Applied Medical Research, Liverpool2170, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH